Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

ImQuest (IQP) DuoGel Phase 1 Pharmacokinetic Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03082690
Recruitment Status : Active, not recruiting
First Posted : March 17, 2017
Last Update Posted : July 3, 2019
Sponsor:
Collaborators:
ImQuest Pharmaceuticals, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by (Responsible Party):
Johns Hopkins University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : November 30, 2019
  Estimated Study Completion Date : November 30, 2019